A detailed history of Velan Capital Investment Management LP transactions in Geron Corp stock. As of the latest transaction made, Velan Capital Investment Management LP holds 500,000 shares of GERN stock, worth $2.12 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
500,000
Previous 778,500 35.77%
Holding current value
$2.12 Million
Previous $1.64 Million 0.49%
% of portfolio
1.85%
Previous 1.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.75 - $3.44 $487,375 - $958,040
-278,500 Reduced 35.77%
500,000 $1.65 Million
Q2 2023

Aug 11, 2023

BUY
$1.97 - $3.69 $942,645 - $1.77 Million
478,500 Added 159.5%
778,500 $2.5 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $642,000 - $1.02 Million
300,000 New
300,000 $651,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.6B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.